In the METABRIC dataset including 1,818 patients with breast cancer, the OS was lower in the patients with a higher IGF2R expression level compared with the patients with a lower IGF2R expression level (Figure 2B, P = 0.008). Here, IGF2R is linked to breast carcinoma.